Bristol-Myers Squibb
See the following -
3 Reasons Why Pharma mHealth Apps Have Failed
Pharma mHealth companies are struggling to have an impact on the mHealth app market generating only limited downloads and usage, despite releasing more than 100 pharma mHealth apps for iOS and Android...
- Login to post comments
Amazon Digital Health Talent Grab: Box Exec Reportedly Joins Team
Amazon is quietly building up its digital health tech talent, reportedly poaching a healthcare exec from Box. The Seattle behemoth may be best known for its retail business, but in the background it has a growing footprint in all manner of health technology areas. This latest Amazon talent grab appears to be another move to shore up those...
- Login to post comments
Bristol-Myers Squibb Launches Universal Patient Language (UPL), an Open-Source Resource for Improving Patient Communications
The UPL seeks to improve how complex topics are communicated to patients; Company launches UPL.org to make principles and tools widely available to others. Bristol-Myers Squibb today announced its commitment to moving toward a new way of communicating with patients and caregivers: the Universal Patient Language (UPL). The UPL addresses widely voiced concerns among consumers and health care advocates that communications about medicines are not designed for an optimal patient experience...
- Login to post comments
Conshohocken-Based Non-Profit Aims to Revolutionize Biopharma
What if the next big thing in biopharma wasn’t produced by one of the big pharma companies that line the Northeast corridor between Philadelphia and New York City, but by a whole bunch of them? Conshohocken-based TransCelerate BioPharma is attempting to accomplish this difficult feat by embracing cooperation instead of competition. It is a 501(c)3 non-profit consortium of 18 pharmaceutical companies (and growing) that works with the FDA and global regulators to advance the industry through collaboration with researchers, industry organizations, and federal oversight agencies...
- Login to post comments
You Won't Believe the Outrageous Ways Big Pharma Has Bribed Doctors to Shill Drugs
At the 2010 meeting of the American Psychiatric Association in New Orleans, a psychiatrist from the East coast shared her anger with me about the recent clamp down on Pharma financial perks to doctors. Before news organizations and the 2010 Physician Financial Transparency Reports (also called the Sunshine Act, part of the Affordable Care Act) reported the outrageous amount of money Pharma was giving doctors to prescribe its new, brand-name drugs, there was almost no limit to what was spent to encourage prescribing...
- Login to post comments